- Home
- AIRS
as 04-22-2025 10:30am EST
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | MIAMI BEACH |
| Market Cap: | 333.7M | IPO Year: | 2021 |
| Target Price: | $3.75 | AVG Volume (30 days): | 308.9K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.53 - $9.20 | Next Earning Date: | 05-09-2025 |
| Revenue: | $180,350,000 | Revenue Growth: | -7.95% |
| Revenue Growth (this year): | -5.72% | Revenue Growth (next year): | 5.54% |
Latest AirSculpt Technologies Inc. News
AIRS Breaking Stock News: Dive into AIRS Ticker-Specific Updates for Smart Investing
Zacks
8 days ago
New Strong Sell Stocks for April 14th
Zacks
20 days ago
New Strong Sell Stocks for April 2nd
TipRanks
21 days ago
AirSculpt Technologies price target lowered to $2.50 from $6.50 at Leerink
Zacks
a month ago
New Strong Sell Stocks for March 26th
Simply Wall St.
a month ago
AirSculpt Technologies Full Year 2024 Earnings: EPS Misses Expectations
GuruFocus.com
a month ago
AirSculpt Technologies Inc (AIRS) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...
Thomson Reuters StreetEvents
a month ago
Q4 2024 Airsculpt Technologies Inc Earnings Call
Zacks
a month ago
AirSculpt Technologies, Inc. (AIRS) Reports Q4 Loss, Tops Revenue Estimates
Compare AIRS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AIRS AirSculpt Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.